Neuss, Germany

Frank Wunderlich

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Animal Health Gmbh. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Wunderlich. Retrieved from https://idiyas.com/inventor/frank-wunderlich-csurhc8v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank Wunderlich: Innovator in Veterinary Science

Introduction

Frank Wunderlich is a notable inventor based in Neuss, Germany. He has made significant contributions to the field of veterinary science, particularly in the development of innovative solutions for animal health.

Latest Patents

Wunderlich holds a patent for the "Use of a novel eimeria gene and corresponding protein." This invention relates to a novel oocyst sporocyst protein (EtOs22) belonging to the parasite species. The patent encompasses the polynucleotide encoding this protein, vectors containing this polynucleotide, and cells transformed with these vectors. Additionally, it includes antibodies directed against the protein, vaccines comprising the polynucleotide, the protein, or fragments thereof, and the use of polynucleotide or polypeptide for finding active compounds for treating infections.

Career Highlights

Frank Wunderlich is associated with Bayer Animal Health GmbH, where he has been instrumental in advancing research and development in animal health products. His work has contributed to the understanding and treatment of parasitic infections in animals.

Collaborations

Wunderlich has collaborated with notable colleagues, including Gisela Greif and Ralf Hosse, to further enhance the impact of their research in the field.

Conclusion

Frank Wunderlich's innovative work in veterinary science, particularly through his patent, showcases his commitment to improving animal health. His contributions continue to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…